All-Time Highs For Dow, S&P 500; Nasdaq Lags
at Investor's Business Daily - Tue Dec 23, 4:02PM CST
The Dow Jones industrial average and the S&P 500 hit new all-time highs Tuesday, but the Nasdaq finished lower. Volume was lower on both exchanges, according to preliminary data. Department stores were the best-performing industry group, up nearly...
DDS: 122.53 (+0.53), ALXN: 181.96 (+3.09), XOM: 93.78 (-0.81), M: 64.26 (+0.22), CVX: 113.47 (-0.48)
SmarTrend Watching for Potential Rebound in Shares of Alexion Pharmaceuticals After 4.93% Loss
Comtex SmarTrend(R) - Tue Dec 23, 3:57PM CST
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $176.61 to a high of $189.89. Yesterday, the shares fell 4.9%, which took the trading range below the 3-day low of $184.00 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALXN: 181.96 (+3.09)
Toys, Department Stores Rock, But Biotechs Tumble
at Investor's Business Daily - Tue Dec 23, 11:06AM CST
The euphoria over third-quarter GDP growth of 5% evaporated Tuesday morning, leaving stocks trading mixed at midday, with the Nasdaq leading other indexes off their best levels. The Nasdaq was off 0.1% ,the S&P 500 rose 0.3% and the Dow Jones...
HAS: 55.25 (+0.03), BIIB: 340.89 (+5.13), PCYC: 121.84 (+1.15), M: 64.26 (+0.22), CELG: 109.60 (+3.48), DDS: 122.53 (+0.53), ESRX: 85.48 (-0.40), MAT: 30.22 (-0.16), GILD: 91.29 (+1.84), JCP: 6.50 (-0.24), ALXN: 181.96 (+3.09), ABBV: 66.21 (+1.86)
Pre-Market Scans on Biotech Stocks - Sarepta Therapeutics, Medivation, Alexion Pharma, Alkermes, and Cepheid
PR Newswire - Tue Dec 23, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Sarepta Therapeutics Inc. (NASDAQ: SRPT), Medivation Inc. (NASDAQ: MDVN), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Alkermes PLC (NASDAQ: ALKS), and Cepheid (NASDAQ: CPHD). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, December 22, 2014, the NASDAQ Composite ended at 4,781.42, up 0.34%, the Dow Jones Industrial Average advanced 0.87%, to finish the day at 17,959.44, and the S&P 500 closed at 2,078.54, up 0.38%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 807.53, down 1.15%, while the index has advanced 8.06% in the previous three months. Register for your complimentary reports on these five stocks at:
MDVN: 99.23 (+1.23), SRPT: 13.88 (+0.47), CPHD: 53.39 (+0.51), ALXN: 181.96 (+3.09), ALKS: 56.16 (+1.02)
Insider Trading Alert - SMRT, FII And ALXN Traded By Insiders
at The Street - Mon Dec 22, 12:50PM CST
Stocks with insider trader activity include SMRT, FII and ALXN
FII: 33.86 (+0.26), ALXN: 181.96 (+3.09), SMRT: 14.67 (-0.04)
Alnylam Pharmaceuticals Continues To Post Encouraging Results
Stephen Simpson, CFA - at Seeking Alpha - Mon Dec 22, 11:15AM CST
ALNY: 93.52 (+0.97), MDCO: 27.06 (+0.21), ALXN: 181.96 (+3.09), SNY: 46.35 (+0.50)
J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015
at The Street - Mon Dec 22, 7:23AM CST
Which biotech and pharmaceuticals stocks should investors buy in 2015? JPMorgan named six companies with the best investment cases as part of its top U.S. stocks picks for 2015.
VRX: 140.33 (-0.22), BMRN: 88.18 (+0.89), JAZZ: 165.33 (+1.83), ALXN: 181.96 (+3.09), ILMN: 186.22 (+2.72), BMY: 59.15 (-0.01)
The Market's 10 Best Stocks
Dan Caplinger, The Motley Fool - Motley Fool - Sun Dec 21, 7:02AM CST
Source: Wikimedia Commons. Investors are always searching for the best possible stocks. That's because if you can identify a winning stock before it takes off, it can have a life-changing impact on your finances. In order to find those stocks,...
NFLX: 342.10 (+5.67), NEU: 405.00 (+5.94), MNST: 112.56 (+0.52), OPK: 9.63 (+0.21), GMCR: 137.65 (+1.10), ALXN: 181.96 (+3.09), ILMN: 186.22 (+2.72), AAPL: 112.01 (-0.53), REGN: 400.12 (+6.07), PCLN: 1,149.78 (+2.17)
Alexion's Rare Disease Model Analyzed
William Meyers - at Seeking Alpha - Thu Dec 18, 2:23PM CST
GILD: 91.29 (+1.84), ALXN: 181.96 (+3.09)
Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders
at The Street - Wed Dec 17, 12:45PM CST
Stocks with insider trader activity include DXCM, ALXN and FRGI
DXCM: 54.94 (+0.99), ALXN: 181.96 (+3.09), FRGI: 56.97 (+0.47)
Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 17, 9:26AM CST
It has been a relatively quiet week with the holiday season coming up though a few companies came out with important pipeline updates.
CYCC: 0.69 (+0.01), CBST: 100.29 (-0.09), SPHS: 0.46 (+0.02), CCXI: 6.64 (-0.04), ALXN: 181.96 (+3.09), EXEL: 1.29 (-0.01)
3 Companies Growing Faster Than MannKind Corporation
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 17, 6:03AM CST
Source: MannKind. MannKind shareholders have had quite the year. After more than doubling in the first half of the year, shares have since given back all of their gains and sit essentially unchanged. Despite the stalemate, MannKind could be on...
AKRX: 36.47 (+0.43), ALXN: 181.96 (+3.09), ACOR: 39.14 (+0.74), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18)
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:55PM CST
Alexion Pharmaceuticals, Inc. (ALXN) announced that a new share repurchase program of up to $500 million have been authorized by its board of directors.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), SCMP: 13.75 (+0.44), ALXN: 181.96 (+3.09)
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:15PM CST
Alexion (ALXN) announced that Soliris has received orphan drug designation in Japan for the treatment of myasthenia gravis.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), ALXN: 181.96 (+3.09), AMGN: 160.67 (+3.15)
Alexion to buy back shares
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 6:01AM CST
ALXN: 181.96 (+3.09)
Alexion Announces $500 Million Share Repurchase Program
Business Wire - Mon Dec 15, 5:30AM CST
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the Company's Board of Directors has authorized a new share repurchase program of up to $500 million. The new share repurchase program will take effect upon completion of the Company's current program, which has approximately $22 million remaining of its previously authorized $400 million.
ALXN: 181.96 (+3.09)
Meet 5 Top Biotech Stocks Holding Up In Shaky Market
at Investor's Business Daily - Sat Dec 13, 7:02AM CST
Everyone gets sick, and drastic health problems call for more drastic treatment. That's partly why several top-rated biotech stocks in today's IBD 50 list have held up well despite recent market pressue. Alexion Pharmaceuticals (ALXN), the fourth...
BIIB: 340.89 (+5.13), GILD: 91.29 (+1.84), ALXN: 181.96 (+3.09), AMGN: 160.67 (+3.15), BMY: 59.15 (-0.01), CELG: 109.60 (+3.48)
United Therapeutics: Will It Pass Peers In 2015?
at Investor's Business Daily - Fri Dec 12, 5:11PM CST
Biomed company United Therapeutics is in a strong industry group, and that's a problem. United Therapeutics' (UTHR) three-year earnings growth rate is 26%, good enough for an EPS Rating of 89. However, in a leading group, "good enough" isn't good...
BIIB: 340.89 (+5.13), UTHR: 130.22 (+2.40), ALXN: 181.96 (+3.09), TEVA: 57.09 (+0.33), CELG: 109.60 (+3.48)
IBD 50: Growth Stocks Fight The Fight In Weak Tape
at Investor's Business Daily - Fri Dec 12, 5:11PM CST
The IBD 50's four-week winning streak came to an end Friday as the index of leading growth stocks lost 3% for the week. It was a tough week for the broad market, too, as the S&P 500 lost 3.5%. The IBD 50 generally has had a hard time keeping up with...
MNST: 112.56 (+0.52), SWKS: 74.32 (+0.92), FB: 80.77 (+0.16), AFSI: 54.21 (-0.05), BITA: 72.57 (+0.36), CDW: 35.75 (+0.14), CELG: 109.60 (+3.48), BIDU: 230.98 (-2.18), ALXN: 181.96 (+3.09), FFIV: 135.11 (+1.17), AAPL: 112.01 (-0.53), ROST: 92.72 (-0.60), AVGO: 100.72 (-0.06)